As pharma companies resume full-scale operation after the COVID-19 outbreak, the demand for large-scale peptide therapeutics contract API manufacturing is expected to increase significantly. It is ...
The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...
With the healthcare landscape continually evolving, the generic medicines industry guarantees widespread access to affordable medications for millions of patients worldwide. Generics play a pivotal ...
Sustainability of small-molecule API manufacturing ensures continued success. Improving the sustainability of small-molecule API manufacturing is essential to ensuring the continued success of the ...
News-Medical.Net on MSN
Flow chemistry, AI, and NMR: A next-gen approach to scalable API production
Discover how AI, flow chemistry, and NMR come together in the PiPAC project to revolutionize scalable and autonomous API ...
AbbVie is investing $195m to strengthen domestic active pharmaceutical ingredient (API) production within the US, with the expansion of its manufacturing plant in North Chicago, Illinois. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback